Read + Share
. Correction to "Intratumoral vidutolimod as monotherapy or in combination with
pembrolizumab in patients with programmed cell death 1 blockade-resistant
melanoma: Final analysis from a phase 1b study". Cancer 2025;131:e70188.
PMID: 41400338
|
 |
|
